The dynamical signature of anhedonia in major depressive disorder: positive emotion dynamics, reactivity, and recovery.


Journal

BMC psychiatry
ISSN: 1471-244X
Titre abrégé: BMC Psychiatry
Pays: England
ID NLM: 100968559

Informations de publication

Date de publication:
08 02 2019
Historique:
received: 05 09 2018
accepted: 11 12 2018
entrez: 10 2 2019
pubmed: 10 2 2019
medline: 4 12 2019
Statut: epublish

Résumé

Major Depressive Disorder (MDD) is the leading cause of disability worldwide. The cardinal features of MDD are depressed mood and anhedonia. Anhedonia is defined as a "markedly diminished interest or pleasure in all, or almost all, activities of the day", and has generally been investigated on group-level using retrospective data (e.g. via questionnaire/interview). However, inferences based on group-level findings not necessarily generalize to daily life experiences within individuals. We repeatedly sampled pleasurable experiences within individuals' daily lives by means of Experience Sampling Methods, and compared how positive affect unfolded in the daily life of healthy controls versus patients diagnosed with MDD and anhedonia. We sampled Positive Affect (PA) and reward experiences on 10 semi-random time points a day, for seven days in the daily lives of 47 MDD patients with anhedonia, and 40 controls. Multilevel models showed that anhedonia was associated with low PA, but not to differences in PA dynamics, nor reward frequency in daily life. In reaction to rewards, MDD patients with anhedonia showed no difference in their increase in PA (i.e., PA reactivity), and showed no signs of a faster return to baseline thereafter (i.e., PA recovery). Our results suggest that the dynamical signature of anhedonia in MDD can be described best as a lower average level of PA, and "normal" in terms of PA dynamics, daily reward reactivity and reward recovery. Preregistration: https://osf.io/gmfsc/register/565fb3678c5e4a66b5582f67 . Preprint: https://osf.io/cfkts.

Sections du résumé

BACKGROUND
Major Depressive Disorder (MDD) is the leading cause of disability worldwide. The cardinal features of MDD are depressed mood and anhedonia. Anhedonia is defined as a "markedly diminished interest or pleasure in all, or almost all, activities of the day", and has generally been investigated on group-level using retrospective data (e.g. via questionnaire/interview). However, inferences based on group-level findings not necessarily generalize to daily life experiences within individuals.
METHODS
We repeatedly sampled pleasurable experiences within individuals' daily lives by means of Experience Sampling Methods, and compared how positive affect unfolded in the daily life of healthy controls versus patients diagnosed with MDD and anhedonia. We sampled Positive Affect (PA) and reward experiences on 10 semi-random time points a day, for seven days in the daily lives of 47 MDD patients with anhedonia, and 40 controls.
RESULTS
Multilevel models showed that anhedonia was associated with low PA, but not to differences in PA dynamics, nor reward frequency in daily life. In reaction to rewards, MDD patients with anhedonia showed no difference in their increase in PA (i.e., PA reactivity), and showed no signs of a faster return to baseline thereafter (i.e., PA recovery).
CONCLUSIONS
Our results suggest that the dynamical signature of anhedonia in MDD can be described best as a lower average level of PA, and "normal" in terms of PA dynamics, daily reward reactivity and reward recovery. Preregistration: https://osf.io/gmfsc/register/565fb3678c5e4a66b5582f67 . Preprint: https://osf.io/cfkts.

Identifiants

pubmed: 30736751
doi: 10.1186/s12888-018-1983-5
pii: 10.1186/s12888-018-1983-5
pmc: PMC6368777
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

59

Références

Clin Psychol Rev. 2008 Apr;28(4):676-91
pubmed: 18006196
Psychol Bull. 2015 Jul;141(4):901-30
pubmed: 25822133
Curr Opin Psychol. 2017 Oct;17:22-26
pubmed: 28950968
J Pers Soc Psychol. 1988 Jun;54(6):1063-70
pubmed: 3397865
Heredity (Edinb). 2005 Sep;95(3):221-7
pubmed: 16077740
J Abnorm Psychol. 2012 Nov;121(4):819-29
pubmed: 22708886
Behav Ther. 2017 Jan;48(1):76-96
pubmed: 28077223
J Abnorm Psychol. 2017 Feb;126(2):149-159
pubmed: 27936838
Psychol Methods. 2008 Dec;13(4):354-75
pubmed: 19071999
Emotion. 2015 Oct;15(5):625-36
pubmed: 25844974
Acta Psychiatr Scand. 2007 Jun;115(6):451-7
pubmed: 17498156
J Abnorm Psychol. 2005 Nov;114(4):627-39
pubmed: 16351385
Br J Clin Psychol. 2012 Jun;51(2):206-22
pubmed: 22574805
J Abnorm Child Psychol. 2016 Jul;44(5):999-1009
pubmed: 26496738
J Abnorm Psychol. 2003 May;112(2):203-11
pubmed: 12784829
J Affect Disord. 2017 Aug 15;218:437-445
pubmed: 28531841
Health Psychol. 2012 Mar;31(2):135-44
pubmed: 21988094
J Abnorm Psychol. 2017 Aug;126(6):713-725
pubmed: 28782974
J Pers Soc Psychol. 1999 May;76(5):805-19
pubmed: 10353204

Auteurs

Vera E Heininga (VE)

Research group of Quantitative Psychology and Individual Differences, KU Leuven, Tiensestraat 102 - bus 3713, 3000, Leuven, Belgium. vera.heininga@kuleuven.be.

Egon Dejonckheere (E)

Research group of Quantitative Psychology and Individual Differences, KU Leuven, Tiensestraat 102 - bus 3713, 3000, Leuven, Belgium.

Marlies Houben (M)

Research group of Quantitative Psychology and Individual Differences, KU Leuven, Tiensestraat 102 - bus 3713, 3000, Leuven, Belgium.

Jasmien Obbels (J)

KU Leuven, Academic Center for ECT and Neuromodulation, Leuven/Kortenberg, University Psychiatric Center KU Leuven, Leuven, Belgium.

Pascal Sienaert (P)

KU Leuven, Academic Center for ECT and Neuromodulation, Leuven/Kortenberg, University Psychiatric Center KU Leuven, Leuven, Belgium.

Bart Leroy (B)

KU Leuven, Academic Center for ECT and Neuromodulation, Leuven/Kortenberg, University Psychiatric Center KU Leuven, Leuven, Belgium.

Joris van Roy (J)

Psychiatric Hospital Alexianen Tienen, Tienen, Belgium.

Peter Kuppens (P)

Research group of Quantitative Psychology and Individual Differences, KU Leuven, Tiensestraat 102 - bus 3713, 3000, Leuven, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH